The construction of clinical specialty capabilities is the fundamental task for the development of hospitals and an important foundation for medical institutions to serve patients. Documents such as the "Healthy China 2030" Planning Outline and the Opinions on Promoting High-Quality Development of Public Hospitals all require strengthening the construction of clinical specialties. The National Health Commission has also specifically issued the "Guiding Opinions on Promoting the Capacity Building of Clinical Specialties", guiding medical institutions to enhance their clinical specialty service capabilities and quality and safety levels, and better serve the high-quality development of hospitals and the Healthy China strategy. Aimed at implementing national policies, promoting medical institutions to build advantageous and characteristic specialties, improve the management system and operation mechanism of clinical specialties, explore technological innovation and development through multi-disciplinary integration, and perfect the quality and safety management system of specialized medical care, etc., to break through the barriers to the development of specialties, enhance the service efficiency of specialties, and activate the internal driving force for the development of specialties The Chengdu High-tech Medical Association specially planned the "Specialized Capacity Building Promotion Action" series of academic conferences - the Multidisciplinary Exchange Academic Salon on Lung Cancer, which was successfully held online on November 12, 2025. This series will focus on topics such as the assessment of specialized capabilities, specialized development planning, discipline cluster construction, clinical specialized management, medical technology innovation, and talent team building. It has invited renowned experts to share advanced experiences, analyze typical cases, and discuss common problems and solutions in the construction of specialized capabilities, promoting the continuous improvement of clinical specialized capabilities in China.